Meet Alfa Cytology at the Cancer R&D 2024, Nov 18-20, 2024. We look forward to connecting with you and providing expert solutions for your cancer drug development projects.

Immune Checkpoint Proteins

Immune Checkpoint Proteins

Human 2B4/CD244/SLAMF4 Protein

CAT#: ICP-A001

Keywords: Human; C-His; Expi293

Inquiry

Human SLAMF1/SLAM/CD150 Protein

CAT#: ICP-A002

Keywords: Human; C-His; Expi293

Inquiry

Human 4-1BB/CD137 Protein

CAT#: ICP-A003

Keywords: Human; C-His; Expi293

Inquiry

Human LILRB1/CD85j/ILT2 Protein

CAT#: ICP-A004

Keywords: Human; C-His-Avi; Expi293

Inquiry

Human LILRB2/CD85d/ILT4 Protein

CAT#: ICP-A005

Keywords: Human; C-His-Avi; Expi293

Inquiry

Human LILRB4/CD85k/ILT3 Protein

CAT#: ICP-A006

Keywords: Human; C-His-Avi; Expi293

Inquiry

Human B7-H3/CD276 Protein

CAT#: ICP-A007

Keywords: Human; C-His; Expi293

Inquiry

Human B7-H4 Protein

CAT#: ICP-A008

Keywords: Human; C-His-Avi; Expi293

Inquiry

Human B7-H3 (4Ig)/B7-H3b Protein

CAT#: ICP-A009

Keywords: Human; C-His-Avi; Expi293

Inquiry

Human CD86/B7-2 Protein

CAT#: ICP-A010

Keywords: Human; C-His-Avi; Expi293

Inquiry

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

First
1
2
3

Alfa Cytology provides its clients with one-stop solutions to accelerate therapeutic discovery and development of brain tumors.

By Disease

Craniopharyngioma

Schwannoma (neuroma)

Pituitary Tumors

Choroid Plexus Tumors

By Molecule Type

Small Molecule Drug

Therapeutic Antibody

Immune Cell Therapy

Oncolytic Virotherapy

Vaccine Development

Contact Us

Copyright © 2024 Alfa Cytology. All rights reserved.